Celularity (CELUW) EBITDA (2019 - 2025)
Celularity (CELUW) reported EBITDA of -$24.4 million for Q4 2025, down 83.23% year-over-year from -$145.3 million in Q4 2024, and down 5.59% quarter-over-quarter from -$23.1 million in Q3 2025.
Celularity (CELUW) EBITDA (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of EBITDA data on file, last reported at -$24.4 million in Q4 2025.
- EBITDA for Q4 2025 came in at -$24.4 million, down 83.23% year-over-year; the trailing twelve-month figure through Dec 2025 was -$91.7 million (down 58.4% YoY), and the FY2025 annual result was -$91.7 million, down 58.4% from the prior year.
- EBITDA retreated to -$24.4 million in Q4 2025 per CELUW's latest filing, from -$23.1 million in the prior quarter.
- Over five years, EBITDA peaked at $49.9 million in Q3 2021 and troughed at -$93.9 million in Q3 2023.
- A 5-year average of -$19.5 million and a median of -$20.9 million in 2024 frame the typical range for EBITDA.
- On a YoY basis, EBITDA climbed as much as 1139.08% in 2021 and fell as far as 29007.3% in 2021.
- A 5-year view of EBITDA shows it stood at -$4.0 million in 2021, then jumped by 699.18% to $24.2 million in 2022, then tumbled by 70.45% to $7.2 million in 2023, then sank by 285.91% to -$13.3 million in 2024, then tumbled by 83.23% to -$24.4 million in 2025.
- Business Quant data shows CELUW's EBITDA at -$24.4 million in Q4 2025, -$23.1 million in Q3 2025, and -$24.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Celularity | - | - | -3.27 Mn | -24.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24.36 Mn |
| Sep 30, 2025 | -23.07 Mn |
| Jun 30, 2025 | -24.53 Mn |
| Mar 31, 2025 | -19.75 Mn |
| Dec 31, 2024 | -13.30 Mn |
| Sep 30, 2024 | -16.10 Mn |
| Jun 30, 2024 | -6.49 Mn |
| Mar 31, 2024 | -22.01 Mn |
| Dec 31, 2023 | 7.15 Mn |
| Sep 30, 2023 | -93.88 Mn |
| Jun 30, 2023 | -48.22 Mn |
| Mar 31, 2023 | -61.36 Mn |
| Dec 31, 2022 | 24.21 Mn |
| Sep 30, 2022 | 5.04 Mn |
| Jun 30, 2022 | 47.83 Mn |
| Mar 31, 2022 | -62.87 Mn |
| Dec 31, 2021 | -4.04 Mn |
| Sep 30, 2021 | 49.94 Mn |
| Jun 30, 2021 | -60.61 Mn |
| Mar 31, 2021 | -44.40 Mn |